Business of Medicine
Feature
Five chronic mistakes that can sabotage your medical practice
Although she says there are no hard and fast rules on how to run a thriving medical group, there are common mistakes that physicians often don’t...
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
Latest News
Physicians may retire en masse soon. What does that mean for medicine?
“It’s a significant concern in terms of whether we have an adequate supply of physicians in the U.S. to meet our nation’s medical care needs....
Latest News
Physician compensation continues to climb amid postpandemic change
Gender-based pay disparity among primary care physicians shrank, and the number of physicians who declined to take new Medicare patients rose.
Opinion
Get action! – Teddy Roosevelt
Explained waits are more tolerable than unexplained waits and giving updates always help. If you’re running an hour late in the office, have your...
Commentary
ChatGPT as a tool in the ob.gyn. office
ChatGPT has the potential to streamline workflow, generate letters to insurance companies, draft clinical plans, and assist with various other...
Opinion
OSHA revisited
Standards most applicable to medical offices are those dealing with personal protective equipment, bloodborne pathogens, hazard communication, and...
Perspectives
Health care in America: Let that tapeworm grow
Might it still be possible to do well while doing good?
Latest News
New Medicare rule streamlines prior authorization in Medicare Advantage plans
About 13% of prior authorization requests that are denied by Medicare Advantage plans actually met Medicare coverage rules.
From the Journals
Outpatient costs top drug costs in some insured, working women with breast cancer
‘Women think they are insured until they get a diagnosis,’ says the author of a new paper.
News
FDA withdraws approval of Makena
The medication was approved in 2011 to reduce the risk for preterm birth, but a postmarketing study did not show clinical benefit.